Statement of Ownership (sc 13g)
February 23 2022 - 6:05AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
INVO
Bioscience, Inc.
(Name
of Issuer)
Common
Stock, par value of $0.0001 per share
(Title
of Class of Securities)
44984F302
(CUSIP
Number)
December
31, 2021
(Date
of Event which Requires Filing of this Statement)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
☒
Rule 13d-1(b)
☐
Rule 13d-1(c)
☐
Rule 13d-1(d)
*
The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover
page.
The
information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of
the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be
subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 44984F302 | 13G | Page 2 of 5 Pages |
1. |
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Claude
Jean Ranoux |
2. |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see
instructions)
(a)
☐
(b)
☐ |
3. |
SEC
USE ONLY
|
4. |
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States |
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH |
5. |
SOLE
VOTING POWER
766,189 |
6. |
SHARED
VOTING POWER
0 |
7. |
SOLE
DISPOSITIVE POWER
766,189 |
8. |
SHARED
DISPOSITIVE POWER
0 |
9. |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
766,189 |
10. |
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see
instructions) ☐
|
11. |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.53% |
12. |
TYPE
OF REPORTING PERSON (see instructions)
IN |
CUSIP No. 44984F302 | 13G | Page 3 of 5 Pages |
Item
1.
|
(a) |
Name
of Issuer
INVO
Bioscience, Inc. |
|
|
|
|
(b) |
Address
of Issuer’s Principal Executive Offices
5582
Broadcast Court
Sarasota,
Florida 34240 |
Item
2.
|
(a) |
Name
of Person Filing
Claude
Jean Ranoux |
|
|
|
|
(b) |
Address
of the Principal Office or, if none, residence
8
Chestnut St.
Winchester,
MA 01890 |
|
|
|
|
(c) |
Citizenship
United
States |
|
|
|
|
(d) |
Title
of Class of Securities
Common
stock, par value $0.0001 per share. |
|
|
|
|
(e) |
CUSIP
Number
CUSIP
number 44984F104 has been assigned to the shares of common stock of the Issuer, which are quoted on the Nasdaq Global Select Market
under the symbol “INVO.” |
Item
3.
Not
applicable.
Item
4. Ownership.
Provide
the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a)
Amount beneficially owned:
766,189
(b)
Percent of class:
6.53%
CUSIP No. 44984F302 | 13G | Page 4 of 5 Pages |
(c)
Number of shares as to which the person has:
|
(i) |
Sole power to vote or to direct the vote |
|
|
766,189 |
|
|
|
|
(ii) |
Shared power to vote or to direct the vote |
|
|
0 |
|
|
|
|
(iii) |
Sole power to dispose or to direct the disposition of |
|
|
766,189 |
|
|
|
|
(iv) |
Shared power to dispose or to direct the disposition of |
|
|
0 |
Item
5. Ownership of Five Percent or Less of a Class.
If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner
of more than five percent of the class of securities, check the following ☐.
Item
6. Ownership of More than Five Percent on Behalf of Another Person.
Not
applicable.
Item
7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
Not
applicable.
Item
8. Identification and Classification of Members of the Group.
Not
applicable.
Item
9. Notice of Dissolution of Group.
Not
applicable.
Item
10. Certification.
Not
applicable.
CUSIP No. 44984F302 | 13G | Page 5 of 5 Pages |
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete
and correct.
|
February
22, 2022 |
|
Date |
|
|
|
/s/
Claude Jean Ranoux |
|
Claude
Jean Ranoux |
INVO BioScience (NASDAQ:INVO)
Historical Stock Chart
From Aug 2024 to Sep 2024
INVO BioScience (NASDAQ:INVO)
Historical Stock Chart
From Sep 2023 to Sep 2024